Pharmacy

05/14/2013 - 8:42am
Almost half of all adults expect to get a flu shot next year

A Harris Interactive poll released found that 44% of all adults reported getting their flu shot this past season, the second time flu shot penetration has reached that high in four years, and even more are expected to get a flu shot next season.

05/13/2013 - 3:43pm
AstraZeneca encourages asthma awareness

Drug maker AstraZeneca is encouraging patients with asthma to control their disease and learn about how it may be affecting their lives as part of National Asthma and Allergy Awareness Month, which takes place in May.

05/13/2013 - 3:31pm
N.J. law designed to address prescription eye drop adherence

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

05/13/2013 - 2:49pm
GPhA promotes lobbyist

The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.

05/13/2013 - 1:35pm
FDA ruling on opioid painkiller deals blow to Endo

A ruling by the Food and Drug Administration means that generic versions of an opioid painkiller made by Endo Pharmaceuticals can stay on the market, drawing criticism from the drug maker.

05/10/2013 - 4:31pm
SPCB appoints new education director

The Specialty Pharmacy Certification Board has appointed Terri Smith Moore as the education director, the group said.

05/10/2013 - 3:54pm
Actavis in talks to combine with Warner Chilcott

Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.

05/10/2013 - 11:56am
FDA approves Breo Ellipta for COPD

The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

05/10/2013 - 11:18am
FDA approves Novartis' Ilaris for rare childhood arthritis

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

05/10/2013 - 11:09am
Denovo Biomarkers, ALS-ETF to explore personalized medicine in amyotrophic lateral sclerosis

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

© 2013 Drug Store News. All Rights Reserved.